List of Excipients in API ERYTHROMYCIN ETHYLSUCCINATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ERYTHROMYCIN ETHYLSUCCINATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | E.E.S | erythromycin ethylsuccinate | 24338-100 | D&C RED NO. 30 | |
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | E.E.S | erythromycin ethylsuccinate | 24338-100 | D&C YELLOW NO. 10 | |
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | E.E.S | erythromycin ethylsuccinate | 24338-100 | FD&C RED NO. 40 | |
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | E.E.S | erythromycin ethylsuccinate | 24338-100 | GLYCERYL MONOCAPRYLOCAPRATE | |
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | E.E.S | erythromycin ethylsuccinate | 24338-100 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing ERYTHROMYCIN ETHYLSUCCINATE
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Par Pharmaceutical Inc | erythromycin ethylsuccinate | 0254-1020 | BANANA |
| Par Pharmaceutical Inc | erythromycin ethylsuccinate | 0254-1020 | CARAMEL |
| Par Pharmaceutical Inc | erythromycin ethylsuccinate | 0254-1020 | POLYSORBATE 80 |
| Par Pharmaceutical Inc | erythromycin ethylsuccinate | 0254-1020 | SODIUM CITRATE |
| Par Pharmaceutical Inc | erythromycin ethylsuccinate | 0254-1020 | SUCROSE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for ERYTHROMYCIN ETHYLSUCCINATE
Excipient focus: ANHYDROUS LACTOSE
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | erythromycin ethylsuccinate | 62559-440 |
| ANI Pharmaceuticals Inc | erythromycin ethylsuccinate | 62559-630 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing ANHYDROUS LACTOSE
Excipient focus: ANHYDROUS TRISODIUM CITRATE
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing ANHYDROUS TRISODIUM CITRATE
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing ANHYDROUS TRISODIUM CITRATE
Excipient focus: BANANA
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing BANANA
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | erythromycin ethylsuccinate | 0254-1020 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing BANANA
Excipient focus: CARAMEL
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing CARAMEL
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing CARAMEL
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Wilshire Pharmaceuticals Inc | erythromycin ethylsuccinate | 52536-134 |
| Bryant Ranch Prepack | erythromycin ethylsuccinate | 63629-2500 |
| Bryant Ranch Prepack | erythromycin ethylsuccinate | 72162-1614 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
Excipient focus: CITRIC ACID MONOHYDRATE
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Wilshire Pharmaceuticals Inc | erythromycin ethylsuccinate | 52536-134 |
| Bryant Ranch Prepack | erythromycin ethylsuccinate | 63629-2500 |
| Bryant Ranch Prepack | erythromycin ethylsuccinate | 72162-1614 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: D&C RED NO. 30
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing D&C RED NO. 30
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | erythromycin ethylsuccinate | 24338-100 |
| Carnegie Pharmaceuticals LLC | erythromycin ethylsuccinate | 80005-161 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing D&C RED NO. 30
Excipient focus: D&C YELLOW NO. 10
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | erythromycin ethylsuccinate | 24338-100 |
| Carnegie Pharmaceuticals LLC | erythromycin ethylsuccinate | 80005-161 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing D&C YELLOW NO. 10
Excipient focus: DIMETHICONE
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | erythromycin ethylsuccinate | 62559-440 |
| ANI Pharmaceuticals Inc | erythromycin ethylsuccinate | 62559-630 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing DIMETHICONE
Excipient focus: FD&C RED NO. 3
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| Wilshire Pharmaceuticals Inc | erythromycin ethylsuccinate | 52536-134 |
| Bryant Ranch Prepack | erythromycin ethylsuccinate | 63629-2500 |
| Bryant Ranch Prepack | erythromycin ethylsuccinate | 72162-1614 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing FD&C RED NO. 3
Excipient focus: FD&C RED NO. 40
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing FD&C RED NO. 40
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing FD&C RED NO. 40
Excipient focus: GLYCERYL MONOCAPRYLOCAPRATE
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing GLYCERYL MONOCAPRYLOCAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | erythromycin ethylsuccinate | 24338-100 |
| Carnegie Pharmaceuticals LLC | erythromycin ethylsuccinate | 80005-161 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing GLYCERYL MONOCAPRYLOCAPRATE
Excipient focus: LACTOSE, ANHYDROUS
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing LACTOSE, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | erythromycin ethylsuccinate and sulfisoxazole acetyl | 21695-690 |
| Physicians Total Care Inc | erythromycin ethylsuccinate and sulfisoxazole acetyl | 54868-0971 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing LACTOSE, ANHYDROUS
Excipient focus: MAGNESIUM ALUMINUM SILICATE
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing MAGNESIUM ALUMINUM SILICATE
| Company | Ingredient | NDC |
|---|---|---|
| Wilshire Pharmaceuticals Inc | erythromycin ethylsuccinate | 52536-134 |
| Bryant Ranch Prepack | erythromycin ethylsuccinate | 63629-2500 |
| Bryant Ranch Prepack | erythromycin ethylsuccinate | 72162-1614 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing MAGNESIUM ALUMINUM SILICATE
Excipient focus: MAGNESIUM STEARATE
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing MAGNESIUM STEARATE
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing MAGNESIUM STEARATE
Excipient focus: METHYLPARABEN
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing METHYLPARABEN
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing METHYLPARABEN
Excipient focus: POLACRILIN POTASSIUM
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing POLACRILIN POTASSIUM
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing POLACRILIN POTASSIUM
Excipient focus: POLYETHYLENE GLYCOL
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | erythromycin ethylsuccinate | 24338-100 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYSORBATE 80
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing POLYSORBATE 80
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ALCOHOL
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | erythromycin ethylsuccinate | 24338-100 |
| Carnegie Pharmaceuticals LLC | erythromycin ethylsuccinate | 80005-161 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Carnegie Pharmaceuticals LLC | erythromycin ethylsuccinate | 80005-161 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER
Excipient focus: POVIDONE
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | erythromycin ethylsuccinate and sulfisoxazole acetyl | 21695-690 |
| Physicians Total Care Inc | erythromycin ethylsuccinate and sulfisoxazole acetyl | 54868-0971 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | erythromycin ethylsuccinate | 62559-440 |
| ANI Pharmaceuticals Inc | erythromycin ethylsuccinate | 62559-630 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing POVIDONE K30
Excipient focus: SILICON DIOXIDE
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | erythromycin ethylsuccinate | 62559-440 |
| ANI Pharmaceuticals Inc | erythromycin ethylsuccinate | 62559-630 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM CITRATE
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing SODIUM CITRATE
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing SODIUM CITRATE
Excipient focus: STARCH, CORN
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing STARCH, CORN
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing STARCH, CORN
Excipient focus: SUCROSE
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing SUCROSE
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | erythromycin ethylsuccinate | 24338-100 |
| Carnegie Pharmaceuticals LLC | erythromycin ethylsuccinate | 80005-161 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | erythromycin ethylsuccinate | 24338-100 |
| Carnegie Pharmaceuticals LLC | erythromycin ethylsuccinate | 80005-161 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing TITANIUM DIOXIDE
Excipient focus: XANTHAN GUM
ERYTHROMYCIN ETHYLSUCCINATE drug variants containing XANTHAN GUM
ERYTHROMYCIN ETHYLSUCCINATE drug variants not containing XANTHAN GUM
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links